Loading…
Reported covered position: Chief of Staff, Rep. Michael Conaway // Chief of Staff, Rep. Todd Rokita // Dep. Chief of Staff/Leg. Director, Rep. Sam Johnson
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: INTUIT, INC. AND AFFILIATES · Firm: FEROX STRATEGIES
HR1: OBBB Implementation; Enhance Tax Administration & tax system integrity; Support Tax Simplification and Voluntary Compliance; Support IRS Taxpayer Assistance Programs; Regulation of tax return preparers; S.3948/H.R.7806 - The Direct File Act of 2026.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: INTUIT, INC. AND AFFILIATES · Firm: FEROX STRATEGIES
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
WASTE MANAGEMENT, INC. via FEROX STRATEGIES
2026 · third_quarter · Q3
Issues related to renewable natural gas.
Issues related to solid waste, recycling, waste to energy, and environmental policy.
Source: Senate LDA
| NATIONAL 4-H COUNCIL |
| 27 |
| 2020–2026 |
| NATIONAL RETAIL FEDERATION | 27 | 2021–2026 |
| BROOKS DEVELOPMENT AUTHORITY | 26 | 2019–2026 |
| ELI LILLY AND COMPANY | 24 | 2021–2026 |
| INTUIT, INC. AND AFFILIATES | 22 | 2021–2026 |
| RAI SERVICES COMPANY (FORMERLY KNOWN AS REYNOLDS AMERICAN) | 22 | 2021–2026 |
| ALEXION PHARMACEUTICALS, INC. | 21 | 2021–2026 |
| DECISION SCIENCES INTERNATIONAL CORP | 21 | 2020–2024 |
| EMD SERONO, INC. | 21 | 2022–2026 |
| TELEVISAUNIVISION, INC. | 21 | 2021–2026 |
| BEXAR COUNTY | 20 | 2021–2025 |
| THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS | 16 | 2021–2024 |
| AVIDITY BIOSCIENCES, INC. | 15 | 2023–2026 |
| GLOBAL GRAB TECHNOLOGIES | 15 | 2022–2026 |
| WESTFIELD LLC | 11 | 2019–2022 |
| CURALEAF, INC. | 9 | 2024–2026 |
| DATAROBOT INC | 9 | 2020–2022 |
| FOOD CORPS | 9 | 2022–2024 |
| DLA PIPER LLP (US) ON BEHALF OF ILLUMINA, INC. | 8 | 2021–2023 |
| Fresenius Kabi USA, LLC | 8 | 2025–2026 |
| HISPANIC ACCESS FOUNDATION | 7 | 2024–2025 |
| LKQ CORPORATION | 7 | 2021–2022 |
| RARE DISEASE COMPANY COALITION | 7 | 2025–2026 |
| ALLIANCE FOR AUTOMOTIVE INNOVATION | 6 | 2025–2026 |
| NATIONAL ASSOCIATION FOR LATINO COMMUNITY ASSET BUILDERS | 6 | 2025–2026 |
| PERATON CORPORATION | 6 | 2021 |
| STOKE THERAPEUTICS | 6 | 2025–2026 |
| SURGENEX | 6 | 2025–2026 |
| SYSCO CORPORATION | 6 | 2025–2026 |
| ENHANCED COMPLIANCE SOLUTIONS, INC. | 5 | 2020–2021 |
| WALT DISNEY COMPANY THE | 5 | 2022–2023 |
| APTIV | 4 | 2026 |
| ASSOCIATION FOR ACCESSIBLE MEDICINES | 4 | 2026 |
| ATRIUM THERAPEUTICS | 4 | 2026 |
| CENTER FOR ARTIFICIAL INTELLIGENCE POLICY | 4 | 2023–2024 |
| EQUINOX INTERNATIONAL SAC | 4 | 2021–2022 |
| IOM | 4 | 2021 |
| REMITLY | 4 | 2026 |
| SELF-INSURANCE INSTITUTE OF AMERICA, INC. | 4 | 2022 |
| ZEBRA TECHNOLOGIES CORPORATION | 4 | 2024–2025 |
| AGE IN PLACE | 3 | 2026 |
| CALMETTO MANAGEMENT GROUP (ON BEHALF OF SELF-INSURANCE INSTITUTE OF AMERICA INC) | 3 | 2019–2020 |
| LIFESTYLE BRANDS COALITION (INFORMAL COALITION) | 3 | 2020 |
| NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (NEMA) | 3 | 2025–2026 |
| SEASONAL EMPLOYMENT ALLIANCE | 3 | 2021 |
| GOGO BUSINESS AVIATION LLC | 2 | 2026 |
| MAZE ENVIRONMENTAL | 2 | 2021 |
| THE ERISA INDUSTRY COMMITTEE (ERIC) | 2 | 2026 |
| NATIONAL FOOTBALL LEAGUE | 1 | 2026 |
| NEURELIS, INC. | 1 | 2026 |
HR1: OBBB Implementation; Enhance Tax Administration & tax system integrity; Support Tax Simplification and Voluntary Compliance; Support IRS Taxpayer Assistance Programs; Regulation of tax return preparers.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: INTUIT, INC. AND AFFILIATES · Firm: FEROX STRATEGIES
HR1: OBBB Implementation; Enhance Tax Administration & tax system integrity; Support Tax Simplification and Voluntary Compliance; Support IRS Taxpayer Assistance Programs; Regulation of tax return preparers; FY26 Financial Services and General Government Appropriations IRS Working Group on AI and Tax filing; FY26 Homeland Security Appropriations on report and authorization of cyber security incident reporting harmonization; FY26 MILCONVA Appropriations on VA and SBA report on expansion of programming serving veteran entrepreneurs; S.3948/H.R.7806 - The Direct File Act of 2026.
HR1: OBBB Implementation; Enhance Tax Administration & tax system integrity; Support Tax Simplification and Voluntary Compliance; Support IRS Taxpayer Assistance Programs; Regulation of tax return preparers; S.3948/H.R.7806 - The Direct File Act of 2026.
HR1: OBBB Implementation; Enhance Tax Administration & tax system integrity; Support Tax Simplification and Voluntary Compliance; Support IRS Taxpayer Assistance Programs; Regulation of tax return preparers; FY26 Financial Services and General Government Appropriations IRS Working Group on AI and Tax filing; FY26 Homeland Security Appropriations on report and authorization of cyber security incident reporting harmonization; FY26 MILCONVA Appropriations on VA and SBA report on expansion of programming serving veteran entrepreneurs; S.3948/H.R.7806 - The Direct File Act of 2026.
Promote financial health and literacy for small businesses and consumers; Support greater access to financial services and financial inclusion; Promote payments infrastructure modernization and market competition; H.R. 8395 Payment Access and Consumer Efficiency Act (PACE Act).
Promote financial health and literacy for small businesses and consumers; Support greater access to financial services and financial inclusion; Promote payments infrastructure modernization and market competition; H.R. 8395 Payment Access and Consumer Efficiency Act (PACE Act).
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: FEROX STRATEGIES
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: FEROX STRATEGIES
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: FEROX STRATEGIES
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).
HR1: OBBB Implementation; Enhance Tax Administration & tax system integrity; Support Tax Simplification and Voluntary Compliance; Support IRS Taxpayer Assistance Programs; Regulation of tax return preparers; FY26 Financial Services and General Government Appropriations IRS Working Group on AI and Tax filing; FY26 Homeland Security Appropriations on report and authorization of cyber security incident reporting harmonization; FY26 MILCONVA Appropriations on VA and SBA report on expansion of programming serving veteran entrepreneurs; S.3948/H.R.7806 - The Direct File Act of 2026.
HR1: OBBB Implementation; Enhance Tax Administration & tax system integrity; Support Tax Simplification and Voluntary Compliance; Support IRS Taxpayer Assistance Programs; Regulation of tax return preparers; S.3948/H.R.7806 - The Direct File Act of 2026.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: INTUIT, INC. AND AFFILIATES · Firm: FEROX STRATEGIES
HR1: OBBB Implementation; Enhance Tax Administration & tax system integrity; Support Tax Simplification and Voluntary Compliance; Support IRS Taxpayer Assistance Programs; Regulation of tax return preparers.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: INTUIT, INC. AND AFFILIATES · Firm: FEROX STRATEGIES
HR1: OBBB Implementation; Enhance Tax Administration & tax system integrity; Support Tax Simplification and Voluntary Compliance; Support IRS Taxpayer Assistance Programs; Regulation of tax return preparers.
Issues related to rare disease pharmaceuticals, Orphan Cures H.R. 946, and Pediatric Priority Review Voucher.
Issues related to rare disease pharmaceuticals, Orphan Cures H.R. 946, and Pediatric Priority Review Voucher.
Issues related to rare disease pharmaceuticals, Orphan Cures H.R. 946, and Pediatric Priority Review Voucher.
Issues related to rare disease pharmaceuticals, Orphan Cures H.R. 946, and Pediatric Priority Review Voucher.
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: FEROX STRATEGIES
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC. · Firm: FEROX STRATEGIES
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act (ECAPS).
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC. · Firm: FEROX STRATEGIES
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act (ECAPS).
Issues related to the pharmaceutical industry. (H.R.1577 and S. 596) - Treat and Reduce Obesity Act of 2021.
Issues related to the pharmaceutical industry. (H.R.1577 and S. 596) - Treat and Reduce Obesity Act of 2021.
Issues related to the pharmaceutical industry. (H.R.1577 and S. 596) - Treat and Reduce Obesity Act of 2021.
Issues related to the pharmaceutical industry. (H.R.1577 and S. 596) - Treat and Reduce Obesity Act of 2021.
Consolidated Appropriations Act, 2023
Client: INTUIT, INC. AND AFFILIATES · Firm: FEROX STRATEGIES
Enhance Tax Administration & tax system integrity. Support Tax Simplification and Voluntary Compliance. Support IRS Taxpayer Assistance Programs. Support strengthening anti-cyberfraud protections for tax system and taxpayers. FY23 Financial Services and General Government Appropriations. H.R. 2617 Consolidated Appropriations Act 2023.
Infrastructure Investment and Jobs Act
Client: DECISION SCIENCES INTERNATIONAL CORP · Firm: FEROX STRATEGIES
General issues related to Transportation Appropriations. INVEST in America Act/Infrastructure Investment and Jobs Act (H.R. 3684).
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457.
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457.
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457.
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457.
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457.
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457.
Inflation Reduction Act of 2022
Client: INTUIT, INC. AND AFFILIATES · Firm: FEROX STRATEGIES
Enhance Tax Administration & tax system integrity. Support Tax Simplification and Voluntary Compliance. Support IRS Taxpayer Assistance Programs. Support strengthening anti-cyberfraud protections for tax system and taxpayers. H.R. 5376 Build Back Better Act.
Inflation Reduction Act of 2022
Client: INTUIT, INC. AND AFFILIATES · Firm: FEROX STRATEGIES
Enhance Tax Administration & tax system integrity. Support Tax Simplification and Voluntary Compliance. Support IRS Taxpayer Assistance Programs. Support strengthening anti-cyberfraud protections for tax system and taxpayers. H.R. 5376 Build Back Better Act/Pub.L. 117-169 Inflation Reduction Act. FY23 Financial Services and General Government Appropriations.
Inflation Reduction Act of 2022
Client: INTUIT, INC. AND AFFILIATES · Firm: FEROX STRATEGIES
Enhance Tax Administration & tax system integrity. Support Tax Simplification and Voluntary Compliance. Support IRS Taxpayer Assistance Programs. Support strengthening anti-cyberfraud protections for tax system and taxpayers. H.R. 5376 Build Back Better Act.
H.R.840 - Retail Revitalization Act. General issues related to taxation of real estate investment trusts (REITs). Tax issues related to reconciliation legislation.
Restore Protections for Dialysis Patients Act
Client: SELF-INSURANCE INSTITUTE OF AMERICA, INC. · Firm: FEROX STRATEGIES
General issues related to the Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750).
Restore Protections for Dialysis Patients Act
Client: SELF-INSURANCE INSTITUTE OF AMERICA, INC. · Firm: FEROX STRATEGIES
General issues related to the Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750).
Restore Protections for Dialysis Patients Act
Client: SELF-INSURANCE INSTITUTE OF AMERICA, INC. · Firm: FEROX STRATEGIES
General issues related to the Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750).
Restore Protections for Dialysis Patients Act
Client: SELF-INSURANCE INSTITUTE OF AMERICA, INC. · Firm: FEROX STRATEGIES
General issues related to the Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750).
Restore Protections for Dialysis Patients Act
Client: SELF-INSURANCE INSTITUTE OF AMERICA, INC. · Firm: FEROX STRATEGIES
General issues related to the Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750).
Restore Protections for Dialysis Patients Act
Client: SELF-INSURANCE INSTITUTE OF AMERICA, INC. · Firm: FEROX STRATEGIES
General issues related to the Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750).
Restore Protections for Dialysis Patients Act
Client: SELF-INSURANCE INSTITUTE OF AMERICA, INC. · Firm: FEROX STRATEGIES
General issues related to the Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750).
Restore Protections for Dialysis Patients Act
Client: SELF-INSURANCE INSTITUTE OF AMERICA, INC. · Firm: FEROX STRATEGIES
General issues related to the Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750).
Issues related to the pharmaceutical industry. (H.R.1577 and S. 596) - Treat and Reduce Obesity Act of 2021.
Issues related to the pharmaceutical industry. (H.R.1577 and S. 596) - Treat and Reduce Obesity Act of 2021.
Issues related to the pharmaceutical industry. (H.R.1577 and S. 596) - Treat and Reduce Obesity Act of 2021.
Issues related to the pharmaceutical industry. (H.R.1577 and S. 596) - Treat and Reduce Obesity Act of 2021.
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457.
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457.
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457.
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457.
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457.
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457.
Issues related to the pharmaceutical industry. (H.R.1577 and S. 596) - Treat and Reduce Obesity Act of 2021.
Issues related to the pharmaceutical industry. (H.R.1577 and S. 596) - Treat and Reduce Obesity Act of 2021.
Infrastructure Investment and Jobs Act
Client: DECISION SCIENCES INTERNATIONAL CORP · Firm: FEROX STRATEGIES
General issues related to Transportation Appropriations. INVEST in America Act/Infrastructure Investment and Jobs Act (H.R. 3684).
Infrastructure Investment and Jobs Act
Client: DECISION SCIENCES INTERNATIONAL CORP · Firm: FEROX STRATEGIES
General issues related to Transportation Appropriations. INVEST in America Act/Infrastructure Investment and Jobs Act (H.R. 3684).
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457.
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457.
Inflation Reduction Act of 2022
Client: INTUIT, INC. AND AFFILIATES · Firm: FEROX STRATEGIES
Enhance Tax Administration & tax system integrity. Support Tax Simplification and Voluntary Compliance. Support IRS Taxpayer Assistance Programs. Support strengthening anti-cyberfraud protections for tax system and taxpayers. H.R. 5376 Build Back Better Act.
H.R.840 - Retail Revitalization Act. General issues related to taxation of real estate investment trusts (REITs). Tax issues related to reconciliation legislation.
H.R.840 - Retail Revitalization Act. General issues related to taxation of real estate investment trusts (REITs). Tax issues related to reconciliation legislation.
Corporate tax issues. Issues related to COVID-19 relief. H.R.840 - Retail Revitalization Act. General issues related to taxation of real estate investment trusts (REITs).
H.R.840 - Retail Revitalization Act. General issues related to taxation of real estate investment trusts (REITs).
Issues related to the pharmaceutical industry. (H.R.1577 and S. 596) - Treat and Reduce Obesity Act of 2021.
Issues related to the pharmaceutical industry. (H.R.1577 and S. 596) - Treat and Reduce Obesity Act of 2021.
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457.
End Double Taxation of Successful Consumer Claims Act
Client: THE COALITION TO END DOUBLE TAXATION OF CONSUMER CLAIMS · Firm: FEROX STRATEGIES
Support passage of S766 and HR4457.
Craft Beverage Modernization and Tax Reform Act of 2019
Client: DIAGEO NORTH AMERICA · Firm: FEROX STRATEGIES
General issues related to corporate tax and trade policy H.R.3301 - Taxpayer Certainty and Disaster Tax Relief Act of 2019 H.R.1175/S. 362 - Craft Beverage Modernization and Tax Reform Act of 2019 Issues related to COVID-19 tax relief
Craft Beverage Modernization and Tax Reform Act of 2019
Client: DIAGEO NORTH AMERICA · Firm: FEROX STRATEGIES
General issues related to corporate tax and trade policy H.R.3301 - Taxpayer Certainty and Disaster Tax Relief Act of 2019 H.R.1175/S. 362 - Craft Beverage Modernization and Tax Reform Act of 2019 H.R.6201 - Families First Coronavirus Response Act H.R.748 - CARES Act
Craft Beverage Modernization and Tax Reform Act of 2019
Client: DIAGEO NORTH AMERICA · Firm: FEROX STRATEGIES
General issues related to corporate tax and trade policy H.R.3301 - Taxpayer Certainty and Disaster Tax Relief Act of 2019 H.R.1175/S. 362 - Craft Beverage Modernization and Tax Reform Act of 2019 Issues related to COVID-19 tax relief
Craft Beverage Modernization and Tax Reform Act of 2019
Client: DIAGEO NORTH AMERICA · Firm: FEROX STRATEGIES
General issues related to corporate tax and trade policy H.R.3301 - Taxpayer Certainty and Disaster Tax Relief Act of 2019 H.R.1175/S. 362 - Craft Beverage Modernization and Tax Reform Act of 2019 Issues related to COVID-19 tax relief
Consolidated Appropriations Act, 2021
Client: WASTE MANAGEMENT, INC. · Firm: FEROX STRATEGIES
Issues related to solid waste, recycling, waste to energy, and environmental policy Alternative fuel tax credit H.R.133 - Consolidated Appropriations Act, 2021
Policy and oversight related to the generic pharmaceutical industry Issues related to the pharmaceutical supply chain Issues related to drug pricing Issues related to FDA generic drug approval process Issues related to Medicaid Generics Penalty Issues related to federal COVID-19 response S.4134 - A bill to establish a demonstration project to increase access to biosimilar products under the Medicare program Issues related to the consumer price index H.R. 6395/S. 4049 - FY 2021 National Defense Authorization Act H.R.133 - Consolidated Appropriations Act, 2021
General issues related to COVID-19 relief H.R.7079 - Clean Start: Back to Work Tax Credit Act H.R.6776 - JOBS Credit Act of 2020 H.R.7615/S. 4214 - To provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19 Issues related to tax credits for charitable donations of inventory H.R.133 - Consolidated Appropriations Act, 2021
Policy and oversight related to the generic pharmaceutical industry Issues related to the pharmaceutical supply chain Issues related to drug pricing Issues related to FDA generic drug approval process Issues related to Medicaid Generics Penalty Issues related to federal COVID-19 response S.4134 - A bill to establish a demonstration project to increase access to biosimilar products under the Medicare program Issues related to the consumer price index H.R. 6395/S. 4049 - FY 2021 National Defense Authorization Act H.R.133 - Consolidated Appropriations Act, 2021
Consolidated Appropriations Act, 2021
Client: DECISION SCIENCES INTERNATIONAL CORP · Firm: FEROX STRATEGIES
DHS technology at land ports of entry H.R.133 - Consolidated Appropriations Act, 2021 H.R.5273 - Securing America's Ports Act H.R.7944/S. 4224 - Southwest Border Security Technology Improvement Act of 2020
HR 7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021 HR 7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021 H.R.133 - Consolidated Appropriations Act, 2021
General issues related to dietary guidelines General issues related to US/UK trade relationships H.R.133 - Consolidated Appropriations Act, 2021
Protecting Consumer Access to Generic Drugs Act of 2019
Client: VIATRIS INC · Firm: FEROX STRATEGIES
Issues related to drug pricing H.R.1499 - Protecting Consumer Access to Generic Drugs Act of 2019 H.R.938 - BLOCKING Act of 2019 H.R.987 - Strengthening Health Care and Lowering Prescription Drug Costs Act H.R.965/S. 340 - CREATES Act of 2019 H.R.2375/S. 64 - Preserve Access to Affordable Generics and Biosimilars Act H.R.2374/S. 1224 - Stop STALLING Act S.1895 - Lower Health Care Costs Act S.2103 - Affordable Insulin Approvals Now Act S.474 - Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act S.1416 - Affordable Prescriptions for Patients Act of 2019 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.4913 - To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes. H.R.6179 - Increasing Access to Biosimilars Act of 2020 H.R.6201 - Families First Coronavirus Response Act H.R.748 - CARES Act
Issues related to drug pricing H.R.1499 - Protecting Consumer Access to Generic Drugs Act of 2019 H.R.938 - BLOCKING Act of 2019 H.R.987 - Strengthening Health Care and Lowering Prescription Drug Costs Act H.R.965/S. 340 - CREATES Act of 2019 H.R.2375/S. 64 - Preserve Access to Affordable Generics and Biosimilars Act H.R.2374/S. 1224 - Stop STALLING Act S.1895 - Lower Health Care Costs Act S.2103 - Affordable Insulin Approvals Now Act S.474 - Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act S.1416 - Affordable Prescriptions for Patients Act of 2019 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.4913 - To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes. H.R.6179 - Increasing Access to Biosimilars Act of 2020 H.R.6201 - Families First Coronavirus Response Act H.R.748 - CARES Act
Issues related to solid waste, recycling, waste to energy, and environmental policy H.R.5845/S. 3263 - Break Free From Plastic Pollution Act of 2020 General issues related to tax policy General issues related to biofuels H.R.2 - INVEST in America Act
Corporate tax issues General issues related to opportunity zones H.R.2210 - Invest in America Act H.R.6800 - The Heroes Act Issues related to COVID-19 relief
Corporate tax issues H.R.2210 - Invest in America Act Issues related to COVID-19 relief H.R.7809 - HOPE Act of 2020 H.R.7197/S. 4012 - RESTAURANTS Act of 2020 H.R.7079 - Clean Start: Back to Work Tax Credit Act General issues related to taxation of real estate investment trust (REIT) General issues related to transportation security
Corporate tax issues General issues related to opportunity zones H.R.2210 - Invest in America Act H.R.6201 - Families First Coronavirus Response Act H.R.748 - CARES Act
Corporate tax issues H.R.2210 - Invest in America Act Issues related to COVID-19 relief H.R.7809 - HOPE Act of 2020 H.R.7197/S. 4012 - RESTAURANTS Act of 2020 H.R.7079 - Clean Start: Back to Work Tax Credit Act General issues related to taxation of real estate investment trust (REIT)
Issues related to drug pricing H.R.1499 - Protecting Consumer Access to Generic Drugs Act of 2019 H.R.938 - BLOCKING Act of 2019 H.R.987 - Strengthening Health Care and Lowering Prescription Drug Costs Act H.R.965/S. 340 - CREATES Act of 2019 H.R.2375/S. 64 - Preserve Access to Affordable Generics and Biosimilars Act H.R.2374/S. 1224 - Stop STALLING Act S.1895 - Lower Health Care Costs Act S.2103 - Affordable Insulin Approvals Now Act S.474 - Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act S.1416 - Affordable Prescriptions for Patients Act of 2019 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.4913 - To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes. H.R.6179 - Increasing Access to Biosimilars Act of 2020 H.R.6201 - Families First Coronavirus Response Act H.R.748 - CARES Act
Preserve Access to Affordable Generics and Biosimilars Act
Client: VIATRIS INC · Firm: FEROX STRATEGIES
Issues related to drug pricing H.R.1499 - Protecting Consumer Access to Generic Drugs Act of 2019 H.R.938 - BLOCKING Act of 2019 H.R.987 - Strengthening Health Care and Lowering Prescription Drug Costs Act H.R.965/S. 340 - CREATES Act of 2019 H.R.2375/S. 64 - Preserve Access to Affordable Generics and Biosimilars Act H.R.2374/S. 1224 - Stop STALLING Act S.1895 - Lower Health Care Costs Act S.2103 - Affordable Insulin Approvals Now Act S.474 - Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act S.1416 - Affordable Prescriptions for Patients Act of 2019 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.4913 - To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes. H.R.6179 - Increasing Access to Biosimilars Act of 2020 H.R.6201 - Families First Coronavirus Response Act H.R.748 - CARES Act
Agricultural News and Rural Content Act of 2019
Client: NCTA-THE INTERNET & TELEVISION ASSOCIATION · Firm: FEROX STRATEGIES
General issues related to telecommunications, spectrum, and rural broadband General issues related to privacy legislation H.R.2682 - Agricultural News and Rural Content Act of 2019
Agricultural News and Rural Content Act of 2019
Client: NCTA-THE INTERNET & TELEVISION ASSOCIATION · Firm: FEROX STRATEGIES
General issues related to telecommunications, spectrum, and rural broadband General issues related to privacy legislation General issues relation to reauthorization of Satellite Television Extension and Localism Act H.R.2682 - Agricultural News and Rural Content Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: CALMETTO MANAGEMENT GROUP (ON BEHALF OF SELF-INSURANCE INSTITUTE OF AMERICA INC) · Firm: FEROX STRATEGIES
Issues related to surprise medical billing Issues related to drug pricing H.R.861 - End Surprise Billing Act of 2019 S.1531 - Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S.1266 - Protecting Patients from Surprise Medical Bills Act S.474 - Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 S.1895 - Lower Health Care Costs Act H.R.4223 - Protecting Patients from Surprise Medical Bills Act H.R.3502 - Protecting People from Surprise Medical Bills Act H.R.3630 - No Surprises Act H.R.3784 - Air Ambulance Affordability Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Issues related to drug pricing H.R.1499 - Protecting Consumer Access to Generic Drugs Act of 2019 H.R.938 - BLOCKING Act of 2019 H.R.987 - Strengthening Health Care and Lowering Prescription Drug Costs Act H.R.965/S. 340 - CREATES Act of 2019 H.R.2375/S. 64 - Preserve Access to Affordable Generics and Biosimilars Act H.R.2374/S. 1224 - Stop STALLING Act S.1895 - Lower Health Care Costs Act S.2103 - Affordable Insulin Approvals Now Act S.474 - Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act S.1416 - Affordable Prescriptions for Patients Act of 2019 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.4913 - To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes. H.R.6179 - Increasing Access to Biosimilars Act of 2020 H.R.6201 - Families First Coronavirus Response Act H.R.748 - CARES Act
Elijah E. Cummings Lower Drug Costs Now Act
Client: CALMETTO MANAGEMENT GROUP (ON BEHALF OF SELF-INSURANCE INSTITUTE OF AMERICA INC) · Firm: FEROX STRATEGIES
Issues related to surprise medical billing Issues related to drug pricing H.R.861 - End Surprise Billing Act of 2019 S.1531 - Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S.1266 - Protecting Patients from Surprise Medical Bills Act S.474 - Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 S.1895 - Lower Health Care Costs Act H.R.4223 - Protecting Patients from Surprise Medical Bills Act H.R.3502 - Protecting People from Surprise Medical Bills Act H.R.3630 - No Surprises Act H.R.3784 - Air Ambulance Affordability Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Taxpayer Certainty and Disaster Tax Relief Act of 2019
Client: DIAGEO NORTH AMERICA · Firm: FEROX STRATEGIES
General issues related to corporate tax and trade policy H.R.3301 - Taxpayer Certainty and Disaster Tax Relief Act of 2019 H.R.1175/S. 362 - Craft Beverage Modernization and Tax Reform Act of 2019 Issues related to COVID-19 tax relief
Taxpayer Certainty and Disaster Tax Relief Act of 2019
Client: DIAGEO NORTH AMERICA · Firm: FEROX STRATEGIES
General issues related to corporate tax and trade policy H.R.3301 - Taxpayer Certainty and Disaster Tax Relief Act of 2019 H.R.1175/S. 362 - Craft Beverage Modernization and Tax Reform Act of 2019 H.R.6201 - Families First Coronavirus Response Act H.R.748 - CARES Act
Taxpayer Certainty and Disaster Tax Relief Act of 2019
Client: DIAGEO NORTH AMERICA · Firm: FEROX STRATEGIES
General issues related to corporate tax and trade policy H.R.3301 - Taxpayer Certainty and Disaster Tax Relief Act of 2019 H.R.1175/S. 362 - Craft Beverage Modernization and Tax Reform Act of 2019 Issues related to COVID-19 tax relief
Issues related to general tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
WALMART INC. via FEROX STRATEGIES
2026 · third_quarter · Q3
Discussions regarding Medicare coverage for pharmacy services.
General issues related to agriculture.
General issues related to organized retail crime and pricing.
General issues related to trade.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIATRIS INC via FEROX STRATEGIES
2026 · third_quarter · Q3
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).
Trade issues related to generic medicines.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
THE GAP INC. via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to tax.
Policies impacting RFID technology.
General issues related to trade in apparel.
Issues related to customer discounts and loyalty programs.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
TELEVISAUNIVISION, INC. via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to telecommunications.
General issues related to appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SYSCO CORPORATION via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to trade.
General issues related to the food industry.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2026 · third_quarter · Q3
General issues related to skin substitutes.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
STOKE THERAPEUTICS via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to rare disease treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
General issues related to international payments including the de-risking of remittances and taxation of consumers who send remittances. Support greater access to financial services and financial inclusion. Promote payment infrastructure modernization and competition including matters related to nonbank access to FedNow and federal reserve systems.
Issues related to implementation of reconciliation. Issues related to international remittances.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to rare disease treatment development.
General issues related to rare disease treatment.
General issues related to tariffs.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
RAI SERVICES COMPANY (FORMERLY KNOWN AS REYNOLDS AMERICAN) via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to the tobacco industry.
Issues related to illicit trade.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NCTA-THE INTERNET & TELEVISION ASSOCIATION via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to telecommunications, spectrum, and rural broadband. General issues related to privacy legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RETAIL FEDERATION via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to organized retail crime.
General issues related to trade.
General Issues related to technology and artificial intelligence.
NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (NEMA) via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to radiopharmaceutical tariffs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
INTUIT, INC. AND AFFILIATES via FEROX STRATEGIES
2026 · third_quarter · Q3
HR1: OBBB Implementation; Enhance Tax Administration & tax system integrity; Support Tax Simplification and Voluntary Compliance; Support IRS Taxpayer Assistance Programs; Regulation of tax return preparers; S.3948/H.R.7806 - The Direct File Act of 2026.
Promote financial health and literacy for small businesses and consumers; Support greater access to financial services and financial inclusion; Promote payments infrastructure modernization and market competition; H.R. 8395 Payment Access and Consumer Efficiency Act (PACE Act).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Treasury, Dept of
GOGO BUSINESS AVIATION LLC via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to aviation.
General issues related to inflight communications.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS KABI USA LLC via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to trade.
General healthcare issues related to biosimilar industries.
General patent issues related to biosimilar industries.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
THE ERISA INDUSTRY COMMITTEE (ERIC) via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to employer sponsored health plans.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to tax.
General issues related to trade.
General issues related to the semiconductor and life-science material manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via FEROX STRATEGIES
2026 · third_quarter · Q3
Issues related to the pharmaceutical industry. Issues related to treating and reducing obesity. Issues related to drug shortages and counterfeit products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIAGEO NORTH AMERICA via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to corporate tax and trade policy.
Dietary guidelines
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
CURALEAF INC. via FEROX STRATEGIES
2026 · third_quarter · Q3
General tax issues surrounding cannabis.
General cannabis rescheduling issues
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Treasury, Dept of
BROOKS DEVELOPMENT AUTHORITY via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to transportation and infrastructure.
General issues related to economic development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AVIDITY BIOSCIENCES, INC. via FEROX STRATEGIES
2026 · third_quarter · 3T
Issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ATRIUM THERAPEUTICS via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
General issues related to trade.
General issues related to the automotive manufacturing industry.
General issues related to the defense industry.
ALLIANCE FOR AUTOMOTIVE INNOVATION via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to the automotive manufacturing industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to the rare disease pharmaceutical ecosystem.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to generic development and commercialization.
General issues related to trade.
General issues related to treatment access.
GOGO BUSINESS AVIATION LLC via FEROX STRATEGIES
2026 · third_quarter · RR
General issues related to aviation and telecommunications.
General issues related to aviation and telecommunications.
NEURELIS, INC. via FEROX STRATEGIES
2026 · third_quarter · RR
General issues related to federal regulation of the healthcare industry.
General issues related to federal regulation of the healthcare industry.
THE ERISA INDUSTRY COMMITTEE (ERIC) via FEROX STRATEGIES
2026 · third_quarter · RR
General issues related to employee sponsored health insurance.
General issues related to employee sponsored health insurance.
WASTE MANAGEMENT, INC. via FEROX STRATEGIES
2026 · second_quarter · Q2
Issues related to renewable natural gas.
Issues related to general tax issues.
Issues related to solid waste, recycling, waste to energy, and environmental policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
WALMART INC. via FEROX STRATEGIES
2026 · second_quarter · Q2
Discussions regarding Medicare coverage for pharmacy services.
General issues related to organized retail crime and pricing.
General issues related to trade.
VIATRIS INC via FEROX STRATEGIES
2026 · second_quarter · Q2
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).
Trade issues related to generic medicines.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
THE GAP INC. via FEROX STRATEGIES
2026 · second_quarter · Q2
Issues related to trade in apparel.
Issues related to tax.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
TELEVISAUNIVISION, INC. via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to appropriations.
General issues related to telecommunications.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SYSCO CORPORATION via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to trade.
General issues related to the food industry.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2026 · second_quarter · Q2
General issues related to skin substitutes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STOKE THERAPEUTICS via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to rare disease treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
General issues related to international payments including the de-risking of remittances and taxation of consumers who send remittances. Support greater access to financial services and financial inclusion. Promote payment infrastructure modernization and competition including matters related to nonbank access to FedNow and federal reserve systems.
Issues related to implementation of reconciliation. Issues related to international remittances.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to tariffs.
General issues related to rare disease treatment.
General issues related to rare disease treatment development.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
RAI SERVICES COMPANY (FORMERLY KNOWN AS REYNOLDS AMERICAN) via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to the tobacco industry.
Issues related to illicit trade.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL FOOTBALL LEAGUE via FEROX STRATEGIES
2026 · second_quarter · Q2
Issues related to the impact of tax legislation on sports leagues.
Issues related to broadcast policies, IP protection, and federal ticket reforms.
Issues relating to stadium security, franchise, federal regulation of sports betting, and drone safety.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NCTA-THE INTERNET & TELEVISION ASSOCIATION via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to telecommunications, spectrum, and rural broadband. General issues related to privacy legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR LATINO COMMUNITY ASSET BUILDERS via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues around opportunity zones.
General issues related to housing.
General issues around CDFIs.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, Treasury, Dept of
NATIONAL RETAIL FEDERATION via FEROX STRATEGIES
2026 · second_quarter · Q2
General Issues related to technology and artificial intelligence.
General issues related to retail.
General issues related to labor and workforce.
NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (NEMA) via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to radiopharmaceutical tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTUIT, INC. AND AFFILIATES via FEROX STRATEGIES
2026 · second_quarter · Q2
HR1: OBBB Implementation; Enhance Tax Administration & tax system integrity; Support Tax Simplification and Voluntary Compliance; Support IRS Taxpayer Assistance Programs; Regulation of tax return preparers; FY26 Financial Services and General Government Appropriations IRS Working Group on AI and Tax filing; FY26 Homeland Security Appropriations on report and authorization of cyber security incident reporting harmonization; FY26 MILCONVA Appropriations on VA and SBA report on expansion of programming serving veteran entrepreneurs; S.3948/H.R.7806 - The Direct File Act of 2026.
Promote financial health and literacy for small businesses and consumers; Support greater access to financial services and financial inclusion; Promote payments infrastructure modernization and market competition; H.R. 8395 Payment Access and Consumer Efficiency Act (PACE Act).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Treasury, Dept of
GLOBAL GRAB TECHNOLOGIES via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to the deployment of technology at ports of entry.
General issues related to Homeland Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS KABI USA LLC via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to trade.
General healthcare issues related to biosimilar industries.
General patent issues related to biosimilar industries.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
EMD SERONO, INC. via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to the semiconductor and life-science material manufacturing.
General issues related to tax.
General issues related to trade.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via FEROX STRATEGIES
2026 · second_quarter · Q2
Issues related to the pharmaceutical industry. Issues related to treating and reducing obesity. Issues related to drug shortages and counterfeit products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIAGEO NORTH AMERICA via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to corporate tax and trade policy.
Dietary guidelines
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
CURALEAF INC. via FEROX STRATEGIES
2026 · second_quarter · Q2
General tax issues surrounding cannabis.
General cannabis rescheduling issues
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Treasury, Dept of
BROOKS DEVELOPMENT AUTHORITY via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to economic development.
General issues related to transportation and infrastructure.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AVIDITY BIOSCIENCES, INC. via FEROX STRATEGIES
2026 · second_quarter · Q2
Issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ATRIUM THERAPEUTICS via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
General issues related to trade.
General issues related to tax.
General issues related to the defense industry.
General issues related to the automotive manufacturing industry.
ALLIANCE FOR AUTOMOTIVE INNOVATION via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to the automotive manufacturing industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to the rare disease pharmaceutical ecosystem.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AGE IN PLACE via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to digital health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
ASSOCIATION FOR ACCESSIBLE MEDICINES via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to generic development and commercialization.
General issues related to treatment access.
General issues related to patents and access to generics/biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
General issues related to the defense industry.
General issues related to tax.
General issues related to the automotive manufacturing industry.
WASTE MANAGEMENT, INC. via FEROX STRATEGIES
2026 · first_quarter · Q1
Issues related to renewable natural gas.
Issues related to general tax issues.
Issues related to solid waste, recycling, waste to energy, and environmental policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
WALMART INC. via FEROX STRATEGIES
2026 · first_quarter · Q1
Discussions regarding Medicare coverage for pharmacy services.
General issues related to agriculture.
General issues related to trade.
VIATRIS INC via FEROX STRATEGIES
2026 · first_quarter · Q1
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).
Trade issues related to generic medicines.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
THE GAP INC. via FEROX STRATEGIES
2026 · first_quarter · Q1
Issues related to tax.
Issues related to trade in apparel.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
TELEVISAUNIVISION, INC. via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to appropriations.
General issues related to telecommunications.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SYSCO CORPORATION via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to trade.
General issues related to the food industry.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2026 · first_quarter · Q1
General issues related to skin substitutes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STOKE THERAPEUTICS via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to rare disease treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
General issues related to international payments including the de-risking of remittances and taxation of consumers who send remittances; Support greater access to financial services and financial inclusion.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to tariffs.
General issues related to rare disease treatment.
General issues related to rare disease treatment development.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RAI SERVICES COMPANY (FORMERLY KNOWN AS REYNOLDS AMERICAN) via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to the tobacco industry.
Issues related to illicit trade.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NCTA-THE INTERNET & TELEVISION ASSOCIATION via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to telecommunications, spectrum, and rural broadband. General issues related to privacy legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR LATINO COMMUNITY ASSET BUILDERS via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to housing.
General issues around CDFIs.
General issues around opportunity zones.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, Treasury, Dept of
NATIONAL RETAIL FEDERATION via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to data privacy.
General issues related to organized retail crime.
General Issues related to technology and artificial intelligence.
NATIONAL 4-H COUNCIL via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to agriculture.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
INTUIT, INC. AND AFFILIATES via FEROX STRATEGIES
2026 · first_quarter · Q1
Promote financial health and literacy for small businesses and consumers; Support greater access to financial services and financial inclusion; Promote payments infrastructure modernization and market competition.
HR1: OBBB Implementation; Enhance Tax Administration & tax system integrity; Support Tax Simplification and Voluntary Compliance; Support IRS Taxpayer Assistance Programs; Regulation of tax return preparers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Treasury, Dept of
FRESENIUS KABI USA LLC via FEROX STRATEGIES
2026 · first_quarter · Q1
General healthcare issues related to biosimilar industries.
General patent issues related to biosimilar industries.
General issues related to trade.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
EMD SERONO, INC. via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to the semiconductor and life-science material manufacturing.
General issues related to trade.
General issues related to tax.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via FEROX STRATEGIES
2026 · first_quarter · Q1
Issues related to the pharmaceutical industry. Issues related to treating and reducing obesity. Issues related to drug shortages and counterfeit products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIAGEO NORTH AMERICA via FEROX STRATEGIES
2026 · first_quarter · Q1
Dietary guidelines
General issues related to corporate tax and trade policy.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
CURALEAF INC. via FEROX STRATEGIES
2026 · first_quarter · Q1
General cannabis rescheduling issues
General tax issues surrounding cannabis.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
BROOKS DEVELOPMENT AUTHORITY via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to economic development.
General issues related to transportation and infrastructure.
Filing targets: General Services Administration (GSA), HOUSE OF REPRESENTATIVES, SENATE
AVIDITY BIOSCIENCES, INC. via FEROX STRATEGIES
2026 · first_quarter · Q1
Issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ATRIUM THERAPEUTICS via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AUTOMOTIVE INNOVATION via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to the automotive manufacturing industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via FEROX STRATEGIES
2026 · first_quarter · Q1
Issues related to rare disease pharmaceuticals, ORPHAN Cures, and Pediatric Priority Review Voucher
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AGE IN PLACE via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to digital health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
ASSOCIATION FOR ACCESSIBLE MEDICINES via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to generic development and commercialization.
General issues related to treatment access.
General issues related to patents and access to generics/biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · RR
General issues related to the automotive and defense industries.
General issues related to the automotive and defense industries.
BROOKS DEVELOPMENT AUTHORITY via FEROX STRATEGIES
2026 · first_quarter · RA
General issues related to economic development.
General issues related to economic development.
2026 · first_quarter · RR
General issues related to international payments.
AGE IN PLACE via FEROX STRATEGIES
2026 · first_quarter · RR
General issues related to digital health.
ASSOCIATION FOR ACCESSIBLE MEDICINES via FEROX STRATEGIES
2026 · first_quarter · RR
General issues related to generic and biosimilar drug development.
General issues related to generic and biosimilar drug development.
General issues related to generic and biosimilar drug development.
ATRIUM THERAPEUTICS via FEROX STRATEGIES
2026 · first_quarter · RR
General issues related to rare disease pharmaceuticals.
General issues related to rare disease pharmaceuticals.
WASTE MANAGEMENT, INC. via FEROX STRATEGIES
2025 · fourth_quarter · Q4
Issues related to solid waste, recycling, waste to energy, and environmental policy.
Issues related to renewable natural gas.
Issues related to general tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
WALMART INC. via FEROX STRATEGIES
2025 · fourth_quarter · Q4
General issues related to trade.
General issues related to agriculture.
General issues related to organized retail crime.
General issues related to labor and workforce.
General issues related to retail.
General issues related to tax.
General issues related to data privacy.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
General issues related to tax.
Filing targets: Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
General issues related to patents and access to generics/biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General issues related to agriculture.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General issues related to organized retail crime.
General issues related to data privacy.
General issues related to trade.
General issues related to tax.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
General issues related to trade.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
General issues related to organized retail crime and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General issues related to tax.
General issues related to retail.
General issues related to trade.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Discussions regarding Medicare coverage for pharmacy services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE